BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mylvaganam RJ, Bailey JI, Sznajder JI, Sala MA; Northwestern Comprehensive COVID Center Consortium. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection. Eur Respir Rev 2021;30:210194. [PMID: 34911696 DOI: 10.1183/16000617.0194-2021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Bernardinello N, Cocconcelli E, Giraudo C, Daverio M, Castelli G, Petrarulo S, Bovo M, Fichera G, Cavinato S, Cattelan AM, Saetta M, Spagnolo P, Balestro E. Predictors of pulmonary sequelae after COVID-19 pneumonia: A 12-month follow-up study. Front Med 2023;10. [DOI: 10.3389/fmed.2023.1084002] [Reference Citation Analysis]
2 Heard-Garris NJ, Brown JF, Ewulonu UC, Goel MS, Gordon AS, Henley C, Khan SS, Smith SM, McColley SA. Anti-racist strategies for clinical and translational research: Design, implementation, and lessons learned from a new course. J Clin Transl Sci 2023;7:e26. [PMID: 36721401 DOI: 10.1017/cts.2022.524] [Reference Citation Analysis]
3 Ling H, Xiao H, Luo T, Lin H, Deng J. Role of Ferroptosis in Regulating the Epithelial-Mesenchymal Transition in Pulmonary Fibrosis. Biomedicines 2023;11. [PMID: 36672671 DOI: 10.3390/biomedicines11010163] [Reference Citation Analysis]
4 Vasichkina E, Alekseeva D, Kudryavtsev I, Glushkova A, Starshinova AY, Malkova A, Kudlay D, Starshinova A. COVID-19 Heart Lesions in Children: Clinical, Diagnostic and Immunological Changes. Int J Mol Sci 2023;24. [PMID: 36674665 DOI: 10.3390/ijms24021147] [Reference Citation Analysis]
5 Zheng Z, Peng F, Zhou Y. Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19? Chinese Medical Journal - Pulmonary and Critical Care Medicine 2023. [DOI: 10.1016/j.pccm.2022.12.002] [Reference Citation Analysis]
6 Chuchalin AG. Pulmonary fibrosis in patients with COVID-19: A review. Terapevticheskii arkhiv 2022;94:1333-1339. [DOI: 10.26442/00403660.2022.11.201943] [Reference Citation Analysis]
7 Kazi AW, Summer R, Sundaram B, George G. Lung recovery with prolonged ECMO following fibrotic COVID-19 acute respiratory distress syndrome. Am J Med Sci 2022:S0002-9629(22)00492-X. [PMID: 36535539 DOI: 10.1016/j.amjms.2022.12.008] [Reference Citation Analysis]
8 Krygier A, Szmajda-Krygier D, Świechowski R, Pietrzak J, Wosiak A, Wodziński D, Balcerczak E. Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients. Biomolecules 2022;12. [PMID: 36551272 DOI: 10.3390/biom12121845] [Reference Citation Analysis]
9 Morell-Hita JL, Rigual-Bobillo JA, Macía-Villa CC. Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients. Reumatol Clin (Engl Ed) 2022;18:625-6. [PMID: 36435559 DOI: 10.1016/j.reumae.2022.06.005] [Reference Citation Analysis]
10 Seo WJ, Kang J, Kang HK, Park SH, Koo HK, Park HK, Lee SS, Song JE, Kwak YG, Kang J. Impact of prior vaccination on clinical outcomes of patients with COVID-19. Emerg Microbes Infect 2022;11:1316-24. [PMID: 35465831 DOI: 10.1080/22221751.2022.2069516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhang Z, Li R, Chen Y, Zhang J, Zheng Y, Xu M, Liang J, Li J, Huang Y, Xu Y, He W, Liu X, Li Y. Association between active cytomegalovirus infection and lung fibroproliferation in adult patients with acute respiratory distress syndrome: a retrospective study. BMC Infect Dis 2022;22:788. [PMID: 36241980 DOI: 10.1186/s12879-022-07747-y] [Reference Citation Analysis]
12 Hua-Huy T, Günther S, Lorut C, Subileau M, Aubourg F, Morbieu C, Marey J, Texereau J, Fajac I, Mouthon L, Roche N, Dinh-Xuan AT. Distal Lung Inflammation Assessed by Alveolar Concentration of Nitric Oxide Is an Individualised Biomarker of Severe COVID-19 Pneumonia. J Pers Med 2022;12:1631. [PMID: 36294770 DOI: 10.3390/jpm12101631] [Reference Citation Analysis]
13 Yuan Y, Qiao G, Zhou J, Zhou Y, Li Y, Li X, Jiang Z, Wang Y. Integrated analysis reveals the protective mechanism and therapeutic potential of hyperbaric oxygen against pulmonary fibrosis. Genes & Diseases 2022. [DOI: 10.1016/j.gendis.2022.08.012] [Reference Citation Analysis]
14 Huang L, Li X, Gu X, Zhang H, Ren L, Guo L, Liu M, Wang Y, Cui D, Wang Y, Zhang X, Shang L, Zhong J, Wang X, Wang J, Cao B. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med 2022;10:863-76. [PMID: 35568052 DOI: 10.1016/S2213-2600(22)00126-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 46.0] [Reference Citation Analysis]
15 Perotin JM, Gierski F, Bolko L, Dury S, Barrière S, Launois C, Dewolf M, Chouabe S, Bongrain E, Picard D, Tran E, N'Guyen Y, Mourvillier B, Servettaz A, Rapin A, Marcus C, Lebargy F, Kaladjian A, Salmon JH, Deslee G. Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19. Respir Res 2022;23:199. [PMID: 35918719 DOI: 10.1186/s12931-022-02111-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Morell-hita JL, Rigual-bobillo JA, Macía-villa CC. Post-COVID-19 interstitial lung disease: A new treatment challenge in rheumatoid arthritis patients. Reumatología Clínica 2022. [DOI: 10.1016/j.reuma.2022.06.002] [Reference Citation Analysis]
17 Jindal SK. Post-COVID Pulmonary Fibrosis: A Medical Quagmire? The Indian Journal of Chest Diseases and Allied Sciences 2022;64:5-7. [DOI: 10.5005/ijcdas-64-1-5] [Reference Citation Analysis]
18 Yeryomenko G, Bezditko T, Ospanova T. THE VIEW OF THE CLINICIAN ON THE PROBLEM OF COVID-19: review. IC 2022;8:217-225. [DOI: 10.35339/ic.8.4.217-225] [Reference Citation Analysis]
19 Bhalla AS, Naranje P, Jayant A. Role of Imaging in Post-COVID-19 Complications. Post COVID-19 Complications and Management 2022. [DOI: 10.1007/978-981-19-4407-9_3] [Reference Citation Analysis]